# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CBD of Denver, Inc. (OTC Pink: CBDD) today announced its unaudited financial results for the second quarter, a three-month peri...
CBD of Denver aims to enter the Germany Cannabis market, testing THC and CBD levels in various samples during a Mary Jane Trade...
Explore CBD of Denver's Q1 2024 earnings with a 293% revenue increase and strategic expansion into the European market. Rea...
CBD of Denver has reported strong fourth-quarter revenues of approximately $1.31m, with $1.13m generated by Luxora and $176,000...
German lawmakers are expecting a recently revised version of the marijuana legalization measure to bring about the long-awaited...
CBD of Denver, Inc. (OTCPK: CBDD) is making strategic moves to broaden the reach of its flagship product, the Magic Lappen, by ...
Colorado-based CBD of Denver, Inc. (OTC Pink: CBDD) announced Thursday that its wholly-owned subsidiary, Luxora, has taken a si...